For the quarter ending 2026-03-31, CRBP has $144,480K in assets. $18,138K in debts. $25,661K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 25,661 | 28,492 | 26,983 | 20,044 |
| Investments | 112,558 | 134,777 | 76,999 | 96,548 |
| Restricted cash | 385 | 670 | 285 | 285 |
| Prepaid expenses and other current assets | 4,962 | 3,015 | 3,304 | 5,948 |
| Total current assets | 143,566 | 166,954 | 107,571 | 122,825 |
| Restricted cash | - | 0 | 385 | 385 |
| Property and equipment, gross | 4,471 | 4,465 | 4,458 | - |
| Less accumulated depreciation | 4,355 | 4,306 | 4,257 | - |
| Property and equipment, net | 116 | 159 | 201 | 251 |
| Operating lease right-of-use assets | 798 | 1,082 | 1,357 | 1,624 |
| Total assets | 144,480 | 168,195 | 109,514 | 125,085 |
| Accounts payable | 435 | 2,215 | 2,740 | 3,988 |
| Accrued expenses | 16,498 | 16,844 | 12,578 | 7,650 |
| Operating lease liabilities | 1,205 | 1,633 | 1,742 | 1,695 |
| Total current liabilities | 18,138 | 20,692 | 17,060 | 13,333 |
| Operating lease liabilities, noncurrent | - | 0 | 307 | 761 |
| Total liabilities | 18,138 | 20,692 | 17,367 | 14,094 |
| Common stock, 0.0001 par value 300,000,000 shares authorized, 17,738,870 and 17,611,511 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 2 | 2 | 1 | 1 |
| Additional paid-in capital | 704,900 | 702,984 | 627,024 | 622,562 |
| Accumulated deficit | -578,399 | -555,430 | -534,875 | -511,533 |
| Accumulated other comprehensive loss | -161 | -53 | -3 | -39 |
| Total stockholders equity | 126,342 | 147,503 | 92,147 | 110,991 |
| Total liabilities and stockholders equity | 144,480 | 168,195 | 109,514 | 125,085 |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)